Chest-oscillation airway secretion-clearing system

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

MAH:

MGC Diagnostics Australia Pty Ltd

class:

Class IIa

manufactured_by:

Respinnovation SAS 611 Chemin de l'Ardrech, Seillans, 83440 France

therapeutic_area:

38124 - Chest-oscillation airway secretion-clearing system

therapeutic_indication:

The RespIn 11 is intended to provide bronchial clearance therapy when external manipulation of the thorax is the physician's choice of treatment. Indications for this form of therapy are described by the American Association for Respiratory Care (AARC) in the Clinical Practices Guidelines for Postural Drainage Therapy' (1991). According to AARC guidelines, specific indications for external manipulation of the thorax include evidence or a suggestion of retained secretions, evidence that the patient is having difficulty with secretion clearance, or presence of atelectasis caused by mucus plugging. In addition, the RespIn 11 is also indicated for external manipulation of the thorax to promote bronchial clearance or improve bronchial drainage for purposes of collecting mucus for diagnostic evaluation

authorization_status:

A

authorization_date:

2019-08-22